跳到主要导航
跳到搜索
跳到主要内容
Pure University (For Demo Only) 国内
帮助和常见问题
English
中文
国内
简介
研究单位
科研成果
设备
数据集
活动
奖项
影响
项目
新闻 / 媒体
按专业知识、名称或附属进行搜索
联系专家
查看 Scopus 资料
Cerný Vladimír
Professor
Dalhousie University
,
Business, Management and Accounting
电子邮件
CV271338
dal
ca
网站
https://www.scopus.com/authid/detail.url?authorId=7102271338
h-index
h10-index
h5-index
7331
引用
33
H-指数
根据存储在 Pure 中的刊物数量以及来自 PlumX 的引用文献数量进行计算
3266
引用
24
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
698
引用
11
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
1997 …
2023
每年的科研成果
综述
指纹
网络
科研成果
(441)
新闻 / 媒体
(26)
相似简介
(6)
指纹
深入其中 Cerný Vladimír 为活跃的研究主题。这些主题标签来自此人的成果。它们共同形成唯一的指纹。
分类
加权
按字母排序
Medicine and Dentistry
Acute Respiratory Distress Syndrome
39%
Anesthesia Induction
17%
Anesthesiology
36%
Artificial Respiration
35%
Bleeding
22%
Blood Pressure
14%
Blood Transfusion
13%
Brain Death
15%
Cadaver
13%
Cannabinoid 1 Receptor
13%
Capillary
13%
Chronic Thromboembolic Pulmonary Hypertension
13%
Clinical Study
14%
Coagulopathy
17%
Cohort Effect
15%
Continuous Positive Airway Pressure
13%
COVID-19
26%
Cytokine
16%
Decision Making
13%
Dexmedetomidine
19%
Diagnosis
16%
Disease
21%
Emergency Care
15%
Experimental Endotoxemia
19%
General Anesthesia
26%
Glycocalyx
46%
Health Care
16%
Heart Arrest
48%
Hospital-Acquired Pneumonia
19%
Hypotension
22%
Hypothermia
19%
Injury
25%
Intensive Care
61%
Intensive Care Medicine
35%
Intensive Care Unit
28%
Levosimendan
13%
Lipopolysaccharide
15%
Microcirculation
100%
Midazolam
14%
Observational Study
47%
Organ Donor
15%
Out of Hospital Cardiac Arrest
15%
Prospective Study
14%
Resuscitation
31%
Sepsis
48%
Sodium Chloride
13%
Terlipressin
14%
Tracheotomy
13%
Ventilator Weaning
19%
Volunteer
14%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
12%
Adult Respiratory Distress Syndrome
39%
Adverse Event
11%
Anemia
8%
Antibiotic Agent
17%
Antibiotic Therapy
10%
Asthma
8%
Bleeding
30%
Blood Clotting Disorder
13%
Blood Clotting Factor 7
19%
Brain Death
18%
Brain Injury
13%
Cadaver
9%
Cannabinoid 1 Receptor
13%
Carbetimer
8%
Chronic Obstructive Lung Disease
13%
Chronic Thromboembolic Pulmonary Hypertension
13%
Cohort Study
13%
Critical Illness
13%
Cytokine
26%
Disease
25%
Experimental Sepsis
26%
Heart Arrest
13%
Hospital Acquired Pneumonia
19%
Hypertensive Factor
14%
Hypotension
16%
Hypothermia
9%
Infection
13%
Inflammation
11%
Injury
39%
Intravital Microscopy
12%
Lipopolysaccharide
13%
Lung Edema
13%
Muscle Fatigue
8%
Neuromuscular Blocking Agent
13%
Normal Human
9%
Observational Study
58%
Peritonitis
18%
Postpartum Hemorrhage
13%
Prevalence
23%
Prospective Study
16%
Sepsis
73%
Septic Shock
32%
Sodium Chloride
13%
Syndrome
9%
Tamoxifen
13%
Terlipressin
14%
Toxic Injury
8%
Tumor Necrosis Factor
12%
Vasopressin
13%
Keyphrases
Acute Critical Illness
6%
Acute Disseminated Encephalomyelitis
6%
Acute Respiratory Distress Syndrome
13%
Anesthesiology
7%
Antibiotics
8%
Cannabinoid Receptor 1 (CB1R)
17%
Capillary Perfusion
7%
Cardiac Surgery
9%
Cardiogenic Pulmonary Edema
13%
CB1R Antagonist
8%
Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
6%
Clinical Application
14%
Clinical Approach
8%
Contrast-enhanced Cardiac Magnetic Resonance
6%
Critically Ill Patients
20%
Cumulative Fluid Balance
6%
Czech Republic
20%
Delayed Contrast Enhancement
6%
Elderly Patients
6%
Endothelial Glycocalyx
15%
Experimental Sepsis
13%
Extended Infusion
6%
First Aid
7%
Functional Capillary Density
11%
Healthcare Referral
6%
Hypotension
8%
Induced Hypothermia
13%
Intensive Care Medicine
9%
Intensive Care Unit
8%
Intestinal Microcirculation
7%
Laboratory Medicine
6%
Left Atrial Function
6%
Levosimendan
13%
LUNG SAFE
7%
Mechanical Ventilation
6%
Meropenem
6%
Monitoring Planning
6%
Orthogonal Polarization Spectral Imaging
7%
Parental Support
6%
Pentobarbital
7%
Perfused Boundary Region
11%
Preanesthetic Evaluation
7%
Prospective Observational Study
19%
Sepsis
18%
Septic Shock
8%
Sidestream Dark Field Imaging
9%
Sublingual Microcirculation
8%
Terlipressin
13%
Therapeutic Temperature
6%
Tracheostomy
8%
